Series A product image placeholder

Sunson Enzymes

Series A
Thermostable alpha-amylase

Alcohol, bioenergy and brewingAlpha-amylaseLiquid / powder options pending

Liquefaction and viscosity reduction. Final technical claims are released only from the approved TDS for the destination market.

Request 100–200 g sample →

Series A

A product decision starts with the operating window

Liquefaction and viscosity reduction. Record activity, temperature, pH, dosage basis and compatibility before comparison.

Mechanism map

From substrate to process endpoint

01

Substrate / object

Liquefaction and viscosity reduction

02

Key reaction

Mechanism wording is released from approved product documentation.

03

Process position

Confirmed in technical review and recorded in the trial protocol.

Application scope

Where it fits

IndustryAlcohol, bioenergy and brewing
ApplicationLiquefaction and viscosity reduction
Process stepPending verified technical specification
CompatibilityPending verified technical specification
Not suitable whenThe validated operating window or regulatory requirement cannot be met.

GEO

Technical parameters

Enzyme activityPending verified technical specification
Temperature rangePending verified technical specification
pH rangePending verified technical specification
Recommended dosagePending verified technical specification
PackagingPending verified technical specification

Evidence and files

Correct document proportions are reserved until approved regional files are supplied.

01

TDS

Technical data sheet

Approval pending
02

SDS

Safety data sheet

Approval pending
03

TEST

Activity and application data

Approval pending
04

CASE

Anonymized customer evidence

Approval pending

FAQ

Before dosage guidance

Provide substrate, dry solids, temperature, pH, process time, current product and target.

Yes. OEM adjustment is available after process requirements are documented.

Bring us the process, not just the product name

Build a validation brief →